Filing Flows

Filing Flows › Consumer Staples › AiXin Life International

AiXin Life International earnings and revenue breakdown

Latest: Q1 2026 · 10-Q filed Nov 9, 2026

Q1 2026 Revenue down 47% year over year to $212K · 251¢ of every $1 of revenue lost · operating margin -255.7%

AiXin Life International made $212K in Q1 2026 (-47% Y/Y): Manufacture and Sale $83K, Hotel $67K, Direct Sales $31K. Operating margin -255.7%, net loss $532K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 9, 2026.

Revenue$212K
Year over year-47%
Operating margin-255.7%
Net earnings−$532K
Operating cash flow−$396K

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $212K in Q1 2026, down 47% year over year and up 154% from the previous quarter. Manufacture and Sale was the largest line at 39% of revenue. Manufacture and Sale lost $179K year over year (down 68%), 96% of the total change.

Operating costs exceeded revenue by $541K, an operating margin of -255.7%. Total costs fell 30% while revenue fell 47%. The fastest-growing cost line was Sales & marketing (+46%). The quarter ended with a net loss of $532K, narrower than the previous quarter's $629K loss.

Operating cash flow was −$396K. Non-cash charges added back $45K of depreciation and amortization. Working capital and other items added $90K.

Quarterly history

AiXin Life International revenue by quarterAiXin Life International revenue by quarter$936KQ3 2024$16KQ4 2024$399KQ1 2025$207KQ2 2025$196KQ3 2025$83KQ4 2025$212KQ1 2026
AiXin Life International net earnings by quarterAiXin Life International net earnings by quarter−$546KQ3 2024−$1.4MQ4 2024−$722KQ1 2025−$352KQ2 2025−$340KQ3 2025−$629KQ4 2025−$532KQ1 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q1 202610-QNov 9, 2026$212K-47%-255.7%−$532K−$396K
Q4 202510-KMay 15, 2026$83K+424%-815.7%−$629K−$262K
Q3 202510-QNov 19, 2025$196K-79%-176.7%−$340K−$622K
Q2 202510-QAug 20, 2025$207K-84%-391.2%−$352K−$475K
Q1 202510-QJun 27, 2025$399K-53%-171.1%−$722K−$676K
Q4 202410-KMay 7, 2025$16K-98%n/m−$1.4M−$1.1M
Q3 202410-QDec 27, 2024$936K-12%-64.4%−$546K−$200K

Charts

AiXin Life International: revenue growth, year over year and quarter over quarterAiXin Life International: revenue growth, year over year and quarter over quarterY/YQ/Q-12%Q3 2024-98%-98%Q4 2024-53%+400%Q1 2025-84%-48%Q2 2025-79%-5%Q3 2025+400%-58%Q4 2025-47%+154%Q1 2026
Latest (Q1 2026): Y/Y -47%, Q/Q +154%.
AiXin Life International: where the cash came from (+) and went (−), TTM to Q1 2026AiXin Life International: where the cash came from (+) and went (−), TTM to Q1 2026Operating cash flow−$1.8MOther financing$1.7MCash drawn (+) / kept (−)$22KNot reconciled−$13KExchange rates$13K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
AiXin Life International: profit against cash, quarter by quarterAiXin Life International: profit against cash, quarter by quarterNet incomeOperating cash flow−$177K$113KQ2 2024−$546K−$200KQ3 2024−$1.4M−$1.1MQ4 2024−$722K−$676KQ1 2025−$352K−$475KQ2 2025−$340K−$622KQ3 2025−$629K−$262KQ4 2025−$532K−$396KQ1 2026
Latest (Q1 2026): Net income −$532K, Operating cash flow −$396K.
AiXin Life International: diluted shares by fiscal yearAiXin Life International: diluted shares by fiscal year66MFY202050MFY202125MFY202225MFY202325MFY202425MFY2025
-61.9% since FY2020: buybacks shrank the count.
AiXin Life International in its industry: growth against margin (4 companies, SIC 5912)AiXin Life International in its industry: growth against margin (4 companies, SIC 5912)revenue growth, year over year →↑ operating marginmedian -2%median 3%CVSGRDNPETSAiXin Life International (-47%, -100%)
Retail-Drug Stores and Proprietary Stores; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About AiXin Life International

Aixin Life International, Inc. (the “Company” or “Aixin Life” or “we”) was incorporated under the laws of the State of Colorado on December 30, 1987. On February 2, 2017, Mr. Quanzhong Lin (Mr. Lin) purchased 65.0 % of the Company’s outstanding shares from China Concentric Capital Group for $ 300,000 , pursuant to a Stock Purchase Agreement dated December 21, 2016, which resulted in a change in control of the Company. On December 12, 2017, pursuant to a Share Exchange Agreement, in consideration for all of the outstanding shares of AiXin (BVI) International Group Co., Ltd. a British Virgin Islands corporation (“AiXin BVI”), the Company issued to Mr. Lin, the sole stockholder of AiXin BVI, shares of common stock then representing 71 % of the outstanding of common stock of the Company.

In its own words, from its 10-Q, filed Nov 9, 2026.

AiXin Life International against its Retail-Drug Stores and Proprietary Stores peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -47% against the peers' median -2%. Operating margin: -255.7% against the peers' median 3.3%.

CompanyQuarterRevenueY/YOp. margin
AiXin Life InternationalQ1 2026$212K-47%-255.7%
CVS CVS HealthQ3 2026$108.4B+5%3.3%
GRDN Guardian Pharmacy ServicesQ3 2026$371M-2%6.8%
PETS Petmed ExpressQ1 FY27$41.0M-20%-15.2%

Source: AiXin Life International 10-Q on SEC EDGAR · CIK 835662 · Retail-Drug Stores and Proprietary Stores